Vivos Therapeutics, Inc. (VVOS) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Vivos Therapeutics, Inc.'s filing signal turned positive.

Vivos Therapeutics, Inc. is a medical technology and healthcare services company focused on non-surgically treating maxillofacial and developmental abnormalities associated with breathing and sleep disorders, primarily obstructive sleep apnea (OSA). The company's core offering, The Vivos Method, combines proprietary oral appliances like the DNA, mRNA, and mmRNA devices with therapeutic treatment protocols. Vivos has pivoted its business model from a dentist-focused approach to a medical-provider focused strategy, emphasizing strategic alliances and acquisitions of sleep centers, exemplified by the acquisition of The Sleep Center of Nevada (SCN). This new model aims to capture diagnostic and consulting revenues through management service organizations (MSOs) and dental service organizations (DSOs), expanding its reach beyond traditional dental providers to a broader range of healthcare professionals.

Revenue is primarily driven by the sale of oral appliances and related therapeutic treatments under The Vivos Method, as well as diagnostic and consulting services from acquired sleep centers.